yasumasa kakei

Has grant

Kobe University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Open

EGFR抵抗性口腔癌におけるYAP阻害剤とナノ粒子の有効性に関する研究

Open Date: 2025-04-01

Close Date: 2028-03-31

Grant: Close

好中球に着眼したシェーグレン症候群の新規病理分類提案と治療薬探索

Open Date: 2023-04-01

Close Date: 2026-03-31

Grant: Close

顎骨壊死に対する腐骨分離促進療法の探索

Open Date: 2023-04-01

Close Date: 2026-03-31

Grant: Close

Development of treatment system for periodontal disease and oral cancer using bio-compatible titanium dioxide

Open Date: 2021-07-09

Close Date: 2023-03-31

Grant: Close

口腔癌における金属ナノ粒子と分子標的薬併用治療の有効性に関する研究

Open Date: 2020-04-01

Close Date: 2024-03-31

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Kobe University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

yasumasa kakei

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Zymosan‐Treated SKG Mice: Assessing Effects of Systemic Inflammation on the Temporomandibular Joint

Changes in Neutrophil Count During Valganciclovir Therapy for Symptomatic Congenital Cytomegalovirus Infection

Efficacy of Ibuprofen Gargle for Oral Lichen Planus: A Single-Center, Placebo-Controlled, Double-Blind, Randomized Crossover Study Trial

Feasibility and potential value of a local governmental frail check-up program for the risk assessment of long-term care in apparently healthy older citizens: a prospective study

Three-year hearing outcomes in infants with congenital cytomegalovirus disease treated with oral valganciclovir: Interim results of a six-year follow-up study in Japan

Safety and efficacy of oral cancer vaccine B440 in patients with PD-1/PD-L1 inhibitor-resistant advanced urothelial cancer: a study protocol for a phase 1 multicenter, open-label, single-arm clinical trial.

Effect and safety of ethanolamine oleate in sclerotherapy in patients with difficult-to-resect venous malformations: A multicenter, single-arm study.

Post-Hoc Analysis of a Multicenter Clinical Trial: Correlation of Coagulation Factor Changes and MRI-Defined Treatment Outcomes After Sclerotherapy for Venous Malformations

Assessment of patients’ characteristics associated with the efficacy and safety of oral valganciclovir treatment for infants with symptomatic congenital cytomegalovirus disease

Efficacy and safety of switching to bilastine, an H1-antihistamine, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a multicenter, open-label, randomized, parallel-group comparative study

Collaborators (7)

Shinya Abe

Kazumichi Fujioka

Ichiro Morioka

Tadashi Nomura

Yoshinori Ito

Naoto Takahashi

Manabu Shigeoka

Make your next move.